Page 17 - Glenmark Pharmaceuticals

Glenmark Pharma falls 16%, records biggest intra-day fall in 7 years

The stock recorded its sharpest intra-day fall since August 19, 2009

Pharma major Glenmark's Ankleshwar plant gets EIR report from USFDA

The stock was trading at Rs 905, up 1.58 per cent from its previous close on BSE

Glenmark ties up with Evestra to develop contraceptive

The companies will file for product approval in FY19

Street awaits fresh triggers for Glenmark Pharmaceuticals

Approvals to launch drugs in US, rebound in domestic growth, debt reduction key for upgrades

Glenmark aims for substantial debt reduction in FY 17

The firm is expecting a strong growth in its US business in the second half of the year.

Glenmark gets US FDA nod for Xylocaine ointment

Glenmark's current portfolio consists of 109 products authorised for distribution in the US and 62 ANDA's pending approval with the US FDA

Glenmark Pharmaceuticals' Q1 net profit up 24% at Rs 227 crore

The company had reported a net profit after tax, minority interest and share of profit of associates of Rs 182.94 crore